Absolute Lymphocyte Count, Platelet-to-Lymphocyte Ratio, and Overall Survival in Eribulin-treated HER2-negative Metastatic Breast Cancer Patients.

Cancer diagnosis & prognosis(2021)

引用 3|浏览0
暂无评分
摘要
ALC and PLR can predict eribulin efficacy in terms of OS, reflecting the antitumour immune response in the microenvironment and indicating eribulin's effectiveness.
更多
查看译文
关键词
Eribulin,absolute lymphocyte count,metastatic breast cancer,neutrophil-to-lymphocyte ratio,overall survival,platelet-to-lymphocyte ratio,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要